Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study.
Liming WangShi-Gao HuangShimei LiMing LiJun ShiWen BaiQianyun WangLibo ZhengYongjun LiuPublished in: Drug design, development and therapy (2019)
UC-MSC cells plus DMARDs therapy can be a safe, effective and feasible therapeutic option for RA patients.
Keyphrases
- rheumatoid arthritis patients
- umbilical cord
- mesenchymal stem cells
- disease activity
- end stage renal disease
- rheumatoid arthritis
- newly diagnosed
- induced apoptosis
- ejection fraction
- chronic kidney disease
- bone marrow
- peritoneal dialysis
- prognostic factors
- systemic lupus erythematosus
- cell therapy
- ankylosing spondylitis
- signaling pathway
- idiopathic pulmonary fibrosis
- patient reported
- systemic sclerosis
- pi k akt